Valvular Disease
10
1
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (10)
NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
Impact of Cardiopulmonary Bypass Time on Gastrointestinal Complications
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
Role of Statins In Slowing Rheumatic Heart Disease (RHD) Progression
Epidemiology and Long-term Outcome of Patients With VHD
Focused Cardiac Ultrasound
T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease
Evaluation of the Brain Natriuretic Peptide as a Predictor of Morbidity and Mortality in Cardiac Surgery
Filling Pressures of the Left Ventricle in Patients With Significant Aortic Stenosis
The Scanner in the Coronary Evaluation